Ipsen is a European specialty pharmaceutical company with strong focus in oncology, rare disease, and neuroscience. The company’s business model is clearly aligned with specialist physician markets and clinically differentiated therapies.
Read More
Ionis Pharmaceuticals is one of the most important RNA medicine companies in rare disease development. The company’s antisense oligonucleotide platform has contributed to approved medicines and partnerships across neurological, metabolic, cardiovascular, and rare genetic disease areas.
Read More
Intellia Therapeutics is a leading developer of in vivo CRISPR-based therapies. Unlike ex vivo approaches that modify cells outside the body, Intellia’s platform is focused on delivering gene editing components directly into patients, particularly for liver-expressed disease targets.
Read More
Inovio Pharmaceuticals is a biotechnology company developing DNA medicines and therapeutic vaccines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.
Read More
Incyte is an established specialty pharmaceutical company focused on oncology, hematology, inflammation, and dermatology. Its commercial foundation is built around specialist-managed disease areas, particularly hematologic malignancies and targeted therapies.
Read More
ICON plc is one of the world’s largest full-service CROs, with major capabilities across clinical trial management, site and patient services, data management, biostatistics, pharmacovigilance, regulatory affairs, decentralized trial support, and real-world evidence. Its acquisition of PRA Health Sciences significantly expanded its global scale and therapeutic coverage.
Read More
Harmony Biosciences is a specialist pharmaceutical company focused on rare neurological and sleep-wake disorders. Its core commercial activity has been associated with narcolepsy, a rare neurological disorder involving excessive daytime sleepiness and cataplexy.
Read More
Halozyme Therapeutics is a biopharmaceutical company whose principal relevance to this ranking lies in drug-delivery technology and partnered biologic formulations. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.
Read More
GSK is one of the world’s leading vaccine developers and one of the most institutionally important companies in preventive immunization. Its vaccine business spans shingles, RSV, meningococcal disease, influenza, hepatitis, pediatric vaccines, and other infectious disease categories.
Read More
Grifols is an established healthcare institution whose principal relevance to this ranking lies in plasma-derived medicines and diagnostic products. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in global Pharmaceutical Companies.
Read More
Gilead Sciences remains one of the most important biotechnology firms globally, with a defining position in antiviral medicine and expanding activity in oncology, cell therapy, and inflammation. The company’s institutional identity has been shaped by scientific and commercial leadership in HIV and hepatitis treatments.
Read More
Genmab is one of Europe’s leading biotechnology firms and a major global player in antibody-based therapeutics. The company is known for its antibody technology platforms, oncology focus, and partnerships with larger pharmaceutical companies. Highest 2026 tier: Tier I Biotechnology Firms 2 ranking categories Overview
Read More
FUJIFILM Diosynth Biotechnologies is one of the fastest-rising global biomanufacturing and CDMO providers, with major capabilities in biologics, vaccines, advanced therapies, microbial fermentation, mammalian cell culture, process development, and commercial manufacturing.
Read More
Fortrea is a major global CRO formed from the clinical development and patient access businesses formerly associated with Labcorp. The company provides clinical trial management, pharmacovigilance, regulatory affairs, data management, clinical pharmacology, and related development services for pharmaceutical and biotechnology sponsors.
Read More
Fate Therapeutics is an established healthcare institution whose principal relevance to this ranking lies in induced-pluripotent-stem-cell-derived cellular immunotherapies. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in cell & Gene Therapy Developers.
Read More
Exelixis is an oncology-focused biopharmaceutical company developing and commercializing cancer medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.
Read More
Evonik Health Care is Evonik’s pharmaceutical ingredients, drug-delivery and contract-manufacturing business. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.
Read More
Ergomed is a specialist CRO and pharmacovigilance services provider with a strong focus on rare disease, oncology, and complex clinical development programs. The company supports pharmaceutical and biotechnology sponsors through clinical trial management, regulatory support, safety services, and post-marketing pharmacovigilance.
Read More
Emmes Group is an established healthcare institution whose principal relevance to this ranking lies in clinical research across public-sector, biotech and rare-disease programs. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations.
Read More
Emergent BioSolutions is an established healthcare institution whose principal relevance to this ranking lies in preparedness vaccines, antibody therapies and manufacturing. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.
Read More